524400 — Ishita Drugs And Industries Income Statement
0.000.00%
Last trade - 00:00- IN₹224.81m
- IN₹180.03m
- IN₹149.97m
- 50
- 35
- 63
- 49
Annual income statement for Ishita Drugs And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 139 | 141 | 121 | 152 | 150 |
| Cost of Revenue | |||||
| Gross Profit | 36.6 | 39.2 | 35.2 | 38.9 | 43.2 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 132 | 131 | 114 | 144 | 141 |
| Operating Profit | 7.72 | 9.61 | 6.32 | 7.97 | 8.92 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 10.5 | 10.4 | 7.79 | 9.87 | 11.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 8.3 | 8.05 | 5.77 | 7.49 | 8.68 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 8.3 | 8.05 | 5.77 | 7.49 | 8.68 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 8.3 | 8.05 | 5.77 | 7.49 | 8.68 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.77 | 2.69 | 1.93 | 2.5 | 2.9 |